Sandesh Mahatme
CIK 1511034 · CFO · last filed 2026-06-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$585.1K
Companies
5
Total Filings
49
Lifetime Open-Market Net
-$50.71M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRSP | Director | — | $49.80 | — | $0 | 3 | 2026-06-09 |
| VOR | CFO | 0 | $14.36 | $0 | $0 | 2 | 2025-12-09 |
| Spyre Therapeutics, Inc. (AGLE) Delisted | Director | — | $12.01 | — | $0 | 7 | 2022-06-09 |
| SRPT | EVP, CFO & CBO | 30,851 | $15.31 | $472.3K | -$50.71M | 29 | 2020-07-09 |
| FLXN | Director | 4,500 | $25.05 | $112.7K | $0 | 8 | 2020-06-12 |
Recent Filings · Page 3 of 5
49 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-02-01 | SRPT | Mixed | — | -$7.16M | EDGAR |
| 2018-10-26 | SRPT | Mixed | −18,124 | -$12.40M | EDGAR |
| 2018-08-08 | SRPT | Tax (F) | −8,501 | -$1.03M | EDGAR |
| 2018-06-21 | FLXN | Grant (A) | — | $0 | EDGAR |
| 2018-06-08 | Spyre Therapeutics, Inc. (AGLE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-05-24 | SRPT | Mixed | +4,625 | -$180.6K | EDGAR |
| 2018-03-16 | SRPT | Mixed | +1,766 | $10 | EDGAR |
| 2018-03-07 | SRPT | Grant (A) | — | $0 | EDGAR |
| 2017-12-05 | Spyre Therapeutics, Inc. (AGLE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-08-07 | SRPT | Mixed | +7,034 | -$237.3K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.